Finance

Beta
Lists
BUW:FRA
Bio Rad Laboratories Inc Class B
€196.00
0.00%
(0.00) 1D
May 27, 3:25:02 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BUW...
Mkt. cap
8.15B
Avg. vol.
1.00
Volume
0.00
52-wk high
€250.00
52-wk low
€185.00
No. of employees
7K
Mkt. cap
8.15B
Avg. vol.
1.00
Volume
0.00
52-wk high
€250.00
52-wk low
€185.00
No. of employees
7K
News stories
From sources across the web
Profile
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide. Wikipedia
About Bio Rad Laboratories Inc Class B
CEONorman David Schwartz
Employees7.45K
Founded1952
HeadquartersHercules, California, United States
SectorHealth care
Websitebio-rad.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
651.60M
653.00M
693.20M
592.10M
Cost of goods sold
306.20M
310.20M
348.40M
282.70M
Cost of revenue
306.20M
310.20M
348.40M
282.70M
Research and development expenses
60.80M
70.60M
66.00M
62.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
205.00M
204.20M
217.30M
212.40M
Operating expense
265.80M
274.80M
283.30M
275.30M
Total operating expenses
572.00M
585.00M
631.70M
558.00M
Operating income
79.60M
68.00M
61.50M
34.10M
Other non operating income
500.00K
-600.00K
-600.00K
700.00K
EBT including unusual items
414.00M
-431.10M
929.20M
-689.80M
EBT excluding unusual items
81.10M
71.70M
81.90M
45.90M
Income tax expense
96.20M
-89.20M
209.20M
-162.70M
Effective tax rate
23.24%
20.69%
22.51%
23.59%
Other operating expenses
-
-
-
-
Net income
317.80M
-341.90M
720.00M
-527.10M
Net profit margin
48.77%
-52.36%
103.87%
-89.02%
Earnings per share
2.61
2.26
2.51
1.89
Interest and investment income
14.70M
13.70M
31.00M
21.00M
Interest expense
-12.60M
-12.30M
-12.10M
-12.30M
Net interest expenses
2.10M
1.40M
18.90M
8.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
120.20M
112.20M
104.00M
75.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer